Castle Biosciences Inc — Quarterly Financial Statistics (NASDAQ:CSTL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 23.34 M24.36 M6.04 M8.75 M22.63 M26.93 M 64.35 M Cash from investing activities 14.79 M-5.77 M22.43 M28.38 M18.39 M-8.83 M 60.37 M Cash from financing activities 838 K-5.38 M1.55 M-101 K919 K4.59 M 6.96 M Free cash flow 16.96 M16.8 M1.3 M-514 K7.8 M19.75 M 28.33 M

Notizie

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call Transcript

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue Estimates

Castle Biosciences Q4 2025: volumi test +42%, ingresso nel mercato AD

Castle Biosciences Q4 2025 slides: test volumes surge 42%, enters AD market

Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up